In the first year following the overturn of Roe v. Wade by the Supreme Court, medication abortion rose sharply, according to new data from researchers.
In the first complete year following the overturn of Roe v. Wade by the Supreme Court, medication abortion rose sharply, according to new data from sexual and reproductive health research group, Guttmacher Institute. Released last week, the Institute’s Monthly Abortion Provision Study indicates that use of medication abortion within the formal health care system in the US has risen from about half, of all abortions in 2020 to nearly two-thirds of all abortions in 2023.
While the Guttmacher Institute data reported in this study only accounts for people who received medication abortions through the formal health care system across the United States, abortion pills are available outside the healthcare system, via online pharmacies, community networks, mail-order pharmacies. Earlier this month, CVS and Walgreens announced that they would begin dispensing mifepristone, one of two medication abortion pills, in its stores in states where abortion is permitted.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Future of medication abortion in the spotlight again ahead of SCOTUS caseThis week, the Supreme Court will take up a case that could have major impacts on women's reproductive healthcare.
Read more »
Future of medication abortion in the spotlight again ahead of SCOTUS caseThis week, the Supreme Court will take up a case that could have major impacts on women's reproductive healthcare.
Read more »
Can the Government Collaborate With Big Tech to Protect Elections?SCOTUS hears a case questioning the validity of that collaboration today.
Read more »
SCOTUS to decide case on how the government talks to social media companiesMurthy v. Missouri could change how platforms deal with covid misinformation, election disinformation, and public emergencies.
Read more »
The Upcoming SCOTUS Abortion Pill Case Could Be the Next DobbsA Supreme Court case by anti-abortion doctors and dentists against the FDA approval of abortion pill mifepristone attempts to block access.
Read more »
SCOTUS Agrees to Hear Case That Could Limit Abortion Pill AccessJessica Corbett is a senior editor and staff writer for Common Dreams.
Read more »